With synthetic correlated diffusion, better and faster cancer diagnosis should...
With synthetic correlated diffusion, better and faster cancer diagnosis should be possible.

Source: Pixabax/jarmoluk

News • Cancer imaging

MRI 2.0 lights up cancerous tissue

Synthetic correlated diffusion is a new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over time.

The innovation, developed by researchers at the University of Waterloo, creates images in which cancerous tissue appears to light up compared to healthy tissue, making it easier to see. "Our studies show this new technology has promising potential to improve cancer screening, prognosis and treatment planning," said Alexander Wong, Canada Research Chair in Artificial Intelligence and Medical Imaging and a professor of systems design engineering at Waterloo.

Irregular packing of cells leads to differences in the way water molecules move in cancerous tissue compared to healthy tissue. The new technology, called synthetic correlated diffusion imaging, highlights these differences by capturing, synthesizing and mixing MRI signals at different gradient pulse strengths and timings.

In the largest study of its kind, the researchers collaborated with medical experts at the Lunenfeld-Tanenbaum Research Institute, several Toronto hospitals and the Ontario Institute for Cancer Research to apply the technology to a cohort of 200 patients with prostate cancer.

Compared to standard MRI techniques, synthetic correlated diffusion imaging was better at delineating significant cancerous tissue, making it a potentially powerful tool for doctors and radiologists.

"Prostate cancer is the second most common cancer in men worldwide and the most frequently diagnosed cancer among men in more developed countries. "That's why we targeted it first in our research. ," said Wong, also a director of the Vision and Image Processing (VIP) Lab at Waterloo. "We also have very promising results for breast cancer screening, detection, and treatment planning. This could be a game-changer for many kinds of cancer imaging and clinical decision support."

Source: University of Waterloo

22.03.2022

Read all latest stories

Related articles

Photo

News • BPE in dense breasts

Breast cancer: elevated MRI enhancement identifies higher risk

A machine learning model found that background parenchymal enhancement (BPE) on breast MRI is an indicator of breast cancer risk in women with extremely dense breasts.

Photo

Article • Additional findings from the MIPA study

Benefits of preoperative breast MRI

Ordering preoperative breast MRI exams of diagnosed breast cancer patients used to be controversial: Did they aid surgical planning better than the combination of mammography and breast ultrasound?…

Photo

Article • Supplemental imaging

The next breast screening advancement: Contrast-enhanced mammography

With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for…

Related products

Subscribe to Newsletter